| Authors: |
Azevedo RS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nooruddin Z; Division of Hematology and Oncology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Bhatia S; Division of Hematology and Oncology, Community Health Network MD Anderson Indianapolis, Indianapolis, IN, USA., Finn L; Division of Hematology, Ochsner Clinic Foundation, Baton Rouge, LA, USA., Davis C; Division of Hematology, Ochsner Clinic Foundation, New Orleans, LA, USA., Alsfeld LC; Division of Hematology, Ochsner Clinic Foundation, New Orleans, LA, USA., Subbiah S; Division of Hematology, Ochsner Clinic Foundation, New Orleans, LA, USA., Norkin M; Division of Hematology/Oncology, Baptist MD Anderson Cancer Center, Jacksonville, FL, USA., Ulrickson M; Division of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA., De La Fuente A; Department of Hematology, MD Anderson Cancer Center Madrid, Madrid, Spain., Larson ML; Leukemia Program, Rush University Medical Center, Chicago, IL, USA., Budak-Alpdogan T; Department of Hematology and Oncology, Cooper University Hospital, Camden, NJ, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
